financetom
Business
financetom
/
Business
/
TaskUs Shareholders Reject Take-Private Deal, Shares Fall
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TaskUs Shareholders Reject Take-Private Deal, Shares Fall
Oct 8, 2025 1:11 PM

03:43 PM EDT, 10/08/2025 (MT Newswires) -- TaskUs ( TASK ) said Wednesday its shareholders rejected proposed take-private deal with a buyer group, including a Blackstone (BX) affiliate, in a special meeting, sending shares down over 12%.

At the meeting, the outsourced digital services provider did not receive necessary votes to approve the transaction agreement with the buyer group, which consists of an affiliate of Blackstone, TaskUS ( TASK ) chief executive officer Bryce Maddock, and co-founder and president Jaspar Weir.

The company does not intend to hold another special meeting and expects to terminate the proposed offer, it added.

Price: 15.00, Change: -2.09, Percent Change: -12.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
Teladoc, LifeMD tie up with Lilly's pharmacy partner to offer Zepbound
Mar 6, 2025
March 6 (Reuters) - Telehealth firms Teladoc and LifeMD ( LFMD ) said on Thursday they had signed an agreement with Gifthealth, the pharmacy partner of Eli Lilly's ( LLY ) direct-to-consumer site, LillyDirect, to offer patients the weight-loss drug, Zepbound. Telehealth companies have previously offered compounded versions of weight-loss treatments when the drugs were in shortage. However, with the...
BRIEF-Willdan Strengthens Electrical Engineering Capabilities With The Acquisition Of APG
BRIEF-Willdan Strengthens Electrical Engineering Capabilities With The Acquisition Of APG
Mar 6, 2025
March 6 (Reuters) - Willdan Group Inc ( WLDN ): * WILLDAN STRENGTHENS ELECTRICAL ENGINEERING CAPABILITIES WITH THE ACQUISITION OF APG * WILLDAN GROUP INC ( WLDN ): TRANSACTION TERMS WERE NOT DISCLOSED * WILLDAN GROUP INC ( WLDN ) - ACQUIRES ALTERNATIVE POWER GENERATION IN STOCK PURCHASE Source text: Further company coverage: ([email protected]) ...
BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering
BRIEF-Advanced Biomed Announces Pricing Of Initial Public Offering
Mar 6, 2025
March 6 (Reuters) - Advanced Biomed Inc: * ADVANCED BIOMED INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING * ADVANCED BIOMED: PRICING OF IPO OF 1.6 MILLION SHARES AT $4.00 PER SHARE Source text: Further company coverage: ([email protected]) ...
Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research
Humacyte Partners With Trestle Biotherapeutics on Bioengineered Kidney Research
Mar 6, 2025
09:15 AM EST, 03/06/2025 (MT Newswires) -- Humacyte ( HUMA ) , a commercial-stage company, will collaborate with preclinical-stage firm Trestle Biotherapeutics to explore technology synergies for bioengineering vascularized organs for transplantation, Trestle Biotherapeutics said Thursday. Trestle Bio said the research allows both companies to expand their own R&D programs while looking into the interaction of Trestle Bio's biofabricated human...
Copyright 2023-2025 - www.financetom.com All Rights Reserved